Literature DB >> 1447170

Nonenzymatic glycation of type I collagen. The effects of aging on preferential glycation sites.

K M Reiser1, M A Amigable, J A Last.   

Abstract

The present study was designed to investigate the effects of aging on preferential sites of glucose adduct formation on type I collagen chains. Two CNBr peptides, one from each type of chain in the type I tropocollagen molecule, were investigated in detail: alpha 1(I)CB3 and alpha 2CB3-5. Together these peptides comprise approximately 25% of the total tropocollagen molecule. The CNBr peptides were purified from rat tail tendon, obtained from animals aged 6, 18, and 36 months, by ion exchange chromatography, gel filtration, and high-performance liquid chromatography (HPLC). Sugar adducts were radiolabeled by reduction with NaB3H4. Glycated tryptic peptides were prepared from tryptic digests of alpha 2CB3-5 and alpha 1(I)CB3 by boronate affinity chromatography and HPLC. Peptides were identified by sequencing and by compositional analysis. Preferential sites of glycation were observed in both CB3 and alpha 2CB3-5. Of the 5 lysine residues in CB3, Lys-434 was the favored glycation site. Of the 18 lysine residues and 1 hydroxylysine residue in alpha 2CB3-5, 3 residues (Lys-453, Lys-479, and Lys-924) contained more than 80% of the glucose adducts on the peptide. Preferential glycation sites were highly conserved with aging. In collagen that had been glycated in vitro, the relative distribution of glucose adducts in old animals differed from that of young animals. In vitro experiments suggest that primary structure is the major determinant of preferential glycation sites but that higher order structure may influence the relative distribution of glucose adducts among these preferred sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1447170

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Mapping structural landmarks, ligand binding sites, and missense mutations to the collagen IV heterotrimers predicts major functional domains, novel interactions, and variation in phenotypes in inherited diseases affecting basement membranes.

Authors:  J Des Parkin; James D San Antonio; Vadim Pedchenko; Billy Hudson; Shane T Jensen; Judy Savige
Journal:  Hum Mutat       Date:  2011-02       Impact factor: 4.878

2.  Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion.

Authors:  Kristin L Reigle; Gloria Di Lullo; Kevin R Turner; Jerold A Last; Inna Chervoneva; David E Birk; James L Funderburgh; Elizabeth Elrod; Markus W Germann; Charles Surber; Ralph D Sanderson; James D San Antonio
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

3.  Partial characterization of the molecular nature of collagen-linked fluorescence: role of diabetes and end-stage renal disease.

Authors:  David R Sell; Ina Nemet; Vincent M Monnier
Journal:  Arch Biochem Biophys       Date:  2009-10-30       Impact factor: 4.013

Review 4.  Arterial stiffness: from physiology to clinical implications.

Authors:  Alberto Milan; Francesco Tosello; Ambra Fabbri; Alessandro Vairo; Dario Leone; Michela Chiarlo; Michele Covella; Franco Veglio
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

5.  The role of nonenzymatic glycation and carbonyls in collagen cross-linking for the treatment of keratoconus.

Authors:  Gage Brummer; Stacy Littlechild; Scott McCall; Yuntao Zhang; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

6.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.

Authors:  Yuntao Zhang; Xiuli Mao; Tyler Schwend; Stacy Littlechild; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

7.  Biochemical alterations in collagen IV induced by in vitro glycation.

Authors:  H M Raabe; H Molsen; S M Mlinaric; Y Açil; G H Sinnecker; H Notbohm; K Kruse; P K Müller
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 8.  Alagebrium and Complications of Diabetes Mellitus.

Authors:  Cigdem Toprak; Semra Yigitaslan
Journal:  Eurasian J Med       Date:  2019-10

Review 9.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

10.  Glycation of type I collagen selectively targets the same helical domain lysine sites as lysyl oxidase-mediated cross-linking.

Authors:  David M Hudson; Marilyn Archer; Karen B King; David R Eyre
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.